PP_1170x120_10-25-21

Pataday Once Daily Relief Extra Strength

Alcon announces broad retail availability of Pataday Once Daily Relief Extra Strength

Alcon announces broad retail availability of Pataday Once Daily Relief Extra Strength

GENEVA — Alcon announced that Pataday Once Daily Relief Extra Strength (olopatadine hydrochloride ophthalmic solution 0.7%) is now available in-store and online at U.S. retailers, following its 2020 approval by the Food and Drug Administration (FDA) for sale over-the-counter (O-T-C). As Alcon’s third Rx-to-OTC switch in the past twelve months, Pataday Once Daily Relief Extra Strength

Alcon announces FDA approval of the O-T-C switch of Pataday Once Daily Relief Extra Strength

Alcon announces FDA approval of the O-T-C switch of Pataday Once Daily Relief Extra Strength

GENEVA – Alcon announced Tuesday that Pataday Once Daily Relief Extra Strength (olopatadine hydrochloride ophthalmic solution 0.7%), formerly prescribed as Pazeo, has been approved by the Food and Drug Administration (FDA) for sale over-the-counter (O-T-C) in the United States. Pataday Once Daily Relief Extra Strength is the first and only once daily eye allergy itch